Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
C. Joaquín Cáceres(University of Georgia), Daniel R. Pérez(University of Georgia), Silvia Carnaccini(University of Georgia), Stivalis Cárdenas-García(University of Georgia), Brittany Seibert(University of Georgia), Daniela S. Rajão(University of Georgia), Jun Wang(Rutgers Sexual and Reproductive Health and Rights)
Cited by 62
Related Papers
Universal primer set for the full-length amplification of all influenza A viruses
|Archives of Virology|2001|2.1k
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L
|Science Advances|2020|400
Replication and Transmission of H9N2 Influenza Viruses in Ferrets: Evaluation of Pandemic Potential
|PLoS ONE|2008|293
Discovery of SARS-CoV-2 Papain-like Protease Inhibitors through a Combination of High-Throughput Screening and a FlipGFP-Based Reporter Assay
|ACS Central Science|2021|200
The <i>in vitro</i> antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor
|Emerging Microbes & Infections|2021|190